Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis (Q58785915)
Jump to navigation
Jump to search
scientific article published on 13 August 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis |
scientific article published on 13 August 2018 |
Statements
Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis (English)
Sami Gharbia
Cornel Balta
Hildegard Herman
Marcel Rosu
Judit Váradi
Ildikó Bácskay
Miklós Vecsernyés
Szilvia Gyöngyösi
Sorina N Voicu
Miruna S Stan
Roxana E Cristian
Anca Dinischiotu
13 August 2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference